Detalles de la búsqueda
1.
Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial.
Mol Ther
; 31(7): 2077-2088, 2023 07 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37060176
2.
Sarcopenia and myosteatosis are associated with survival in patients receiving immunotherapy for advanced hepatocellular carcinoma.
Eur Radiol
; 33(1): 512-522, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35864351
3.
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade.
Br J Cancer
; 126(4): 569-575, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34621044
4.
Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma.
BMC Cancer
; 22(1): 219, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35227227
5.
Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma.
Int J Mol Sci
; 22(23)2021 Nov 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884684
6.
A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy.
Oncologist
; 25(9): e1280-e1285, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32271494
7.
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations.
Int J Cancer
; 144(11): 2887-2896, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30485437
8.
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma.
Liver Int
; 39(11): 2184-2189, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31400295
9.
Klotho-beta and fibroblast growth factor 19 expression correlates with early recurrence of resectable hepatocellular carcinoma.
Liver Int
; 39(9): 1682-1691, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30698907
10.
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Gefitinib.
Oncologist
; 22(9): 1075-1083, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28507206
11.
Primary tumor site is a useful predictor of cetuximab efficacy in the third-line or salvage treatment of KRAS wild-type (exon 2 non-mutant) metastatic colorectal cancer: a nationwide cohort study.
BMC Cancer
; 16: 327, 2016 05 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27221731
12.
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia.
Oncologist
; 20(9): 1051-7, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26240133
13.
Young patients with colorectal cancer have increased risk of second primary cancers.
Jpn J Clin Oncol
; 45(11): 1029-35, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386042
14.
Radiosensitization by combining an aurora kinase inhibitor with radiotherapy in hepatocellular carcinoma through cell cycle interruption.
Int J Cancer
; 135(2): 492-501, 2014 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375034
15.
Type 2 diabetes mellitus is associated with increased mortality in Chinese patients receiving curative surgery for colon cancer.
Oncologist
; 19(9): 951-8, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25061090
16.
Phase II multicentered study of low-dose everolimus plus cisplatin and weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin as first-line treatment for patients with advanced gastric cancer.
Oncology
; 87(2): 104-13, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25011938
17.
Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma.
J Gastroenterol Hepatol
; 29(12): 2021-31, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25160036
18.
Changes in Posttreatment Spleen Volume Associated with Immunotherapy Outcomes for Advanced Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 11: 1015-1029, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38854818
19.
Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma.
Cancer
; 119(6): 1210-6, 2013 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23212657
20.
The Aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme.
Oncology
; 84(6): 326-35, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23636005